Terns Pharmaceuticals
TERN
#6759
Rank
A$0.79 B
Marketcap
$9.37
Share price
-3.14%
Change (1 day)
-2.81%
Change (1 year)

Earnings for Terns Pharmaceuticals (TERN)

Earnings in 2024 (TTM): -A$0.15 Billion

According to Terns Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$0.17 Billion a decrease over its 2022 earnings that were of -A$99.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Terns Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.15 Billion-9.45%
2023 -A$0.17 Billion65.34%
2022 -A$99.24 Million24.41%
2021 -A$79.77 Million34.67%
2020 -A$59.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion 34.78%๐Ÿ‡บ๐Ÿ‡ธ USA